Skip to main content

Table 1 Demographic data

From: Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa

Study group Age/gender/study eye Dose (cells) Cell viability (%) Eye IOL BCVA (logMAR) Visual field (degrees) ERG VEP  
        S N I T   Amplitude (mV) Latency (ms)
1 38/M/OD 1 × 106 86.00 OD
OS
No
No
2.00
2.00
10
10
10
10
10
10
10
10
NR
NR
5.465
5.985
N/A
1 58/M/OD 1 × 106 87.5 OD
OS
Yes
Yes
1.40
1.51
10
10
10
10
10
10
10
10
NR
NR
6.357
1.950
98
106
1 58/M/OD 1 × 106 95.70 OD
OS
No
No
1.08
1.30
10
10
10
11
10
10
12
10
NR
NR
2.995
5.725
134
134
1 56/F/OD 1 × 106 93.00 OD
OS
No
No
2.30
2.30
10
25
10
10
15
40
10
24
NR
NR
5.075
6.505
152
145
1 42/M/OD 1 × 106 94.00 OD
OS
No
No
2.30
2.30
10
10
10
10
10
10
10
10
NR
NR
4.615
5.550
105
98
1 46/F/OD 1 × 106 94.05 OD
OS
Yes
Yes
2.30
2.30
N/A N/A N/A N/A NR
NR
5.335
5.465
123
100
1 35/F/OD 1 × 106 86.60 OD
OS
No
No
1.47
1.36
45
55
55
50
70
60
75
72
NR
NR
14.84
11.72
120
119
2 61/M/OD 5 × 106 96.00 OD
OS
Yes
No
1.22
1.08
10
10
10
10
10
10
10
10
NR
NR
4.615
3.645
114
105
2 42/M/OD 5 × 106 96.73 OD
OS
No
No
2.30
2.30
N/A N/A N/A N/A NR
NR
4.680
3.900
106
107
2 48/M/OD 5 × 106 93.75 OD
OS
No
No
2.70
2.70
N/A N/A N/A N/A NR
NR
3.380
2.990
135
121
3 45/F/OD 1 × 107 93.07 OD
OS
Yes
Yes
2.30
2.30
N/A N/A N/A N/A NR
NR
3.510
5.335
131
135
3 37/M/OD 1 × 107 92.58 OD
OS
No
No
2.70
2.30
N/A N/A N/A N/A NR
NR
2.470
4.290
130
128
3 49/M/OD 1 × 107 89.14 OD
OS
Yes
Yes
1.34
2.30
N/A N/A N/A N/A NR
NR
N/A N/A
3 32/F/OD 1 × 107 91.60 OD
OS
No
No
2.00
2.00
10
10
10
10
10
10
10
10
NR
NR
N/A N/A
  1. BCVA best corrected visual acuity, ERG electroretinogram, F female, M male, logMAR logarithm minimum angle of resolution, ms millisecond, mV millivolt, IOL intraocular lens, OD oculus dexter, OS oculus sinister, VEP visual evoked potential, S superior, N nasal, I inferior, T temporal, and NR nonrecordable